Update: Chevron Cabinda Gulf Operations Resume After Release of Oil-January 2024-www.financetom.com

Update: Chevron Cabinda Gulf Operations Resume After Release of Oil

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Update: Chevron Cabinda Gulf Operations Resume After Release of Oil

Jan 28, 2025 2:14 AM

04:58 AM EST, 01/28/2025 (MT Newswires) -- (Updates with attribution to Chevron ( CVX ) throughout and additional information in the last two paragraphs.)

Chevron ( CVX ) said its Cabinda Gulf Oil operations in Angola have resumed normal operations after an oil sheen and debris were found nearby along the Atlantic Ocean coastline.

About five barrels of oil were released into the sea in a matter still under investigation, the company said in a statement emailed Monday to MT Newswires.

"A survey of the facilities and pipelines is currently underway, with no abnormalities detected so far," the company said.

The company added that it is contributing to the cleanup, with efforts focused on three nearby beaches.

Previous page： Marchex Joining Microsoft's Cloud AI Partner Program Next page： European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Marchex Joining Microsoft's Cloud AI Partner Program

Dec 11, 2024

09:33 AM EST, 12/11/2024 (MT Newswires) -- Marchex ( MCHX ) said Wednesday it has signed an agreement to join Microsoft's ( MSFT ) Cloud AI Partner Program. The move will give Marchex ( MCHX ) the ability to transact via Microsoft's ( MSFT ) Azure Marketplace, which will connect clients to its products, the company said. The products will...

European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug

Dec 11, 2024

On Wednesday, Pharming Group N.V. ( PHAR ) revealed topline results of data from its Phase 3 trial evaluating leniolisib in children aged 4 to 11 years with activated phosphoinositide 3-kinase delta syndrome (APDS). APDS is a genetic disorder that impairs the immune system. Individuals with this condition often have low numbers of white blood cells, particularly certain types of...

Wells Fargo CEO expresses more confidence in regulatory fixes

Dec 11, 2024

NEW YORK, Dec 11 (Reuters) - Wells Fargo ( WFC ) CEO Charlie Scharf expressed more confidence on Wednesday in the bank's progress to fix compliance problems after its years-long fake accounts scandal, detailing its efforts to implement risk controls. For every one of our consent orders that we have, for every one of our regulatory deliverables, we have extremely...

Wells Fargo CEO expresses more confidence in regulatory fixes

Dec 11, 2024

NEW YORK (Reuters) - Wells Fargo ( WFC ) CEO Charlie Scharf expressed more confidence on Wednesday in the bank's progress to fix compliance problems after its years-long fake accounts scandal, detailing its efforts to implement risk controls. For every one of our consent orders that we have, for every one of our regulatory deliverables, we have extremely detailed plans...